Presence of the metabolic syndrome distinguishes patients with ketosis-prone diabetes who have a Type 2 diabetic phenotype

Journal of Diabetes and its Complications

Volumn 19, Issue 6, 2005, Pages 313-318

  Otiniano, Max E ^a   Balasubramanyam, Ashok ^a,b   Maldonado, Mario ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BEN TAUB GENERAL HOSPITAL   (United States)

^c Mail Stop J4404 ^*  (United States)

Author keywords

Ethnicity; Ketosis prone diabetes; Metabolic syndrome

Indexed keywords

C PEPTIDE; GLUCAGON; HEMOGLOBIN A1C;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE TEST; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC KETOACIDOSIS; ETHNIC GROUP; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEMOGLOBIN DETERMINATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; SAMPLE SIZE; WORLD HEALTH ORGANIZATION;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GLUCAGON; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; METABOLIC SYNDROME X; PHENOTYPE; PROSPECTIVE STUDIES;

EID: 27644488266     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2005.03.001     Document Type: Article

References (26)

1. AACE/ACE Findings and recommendations from the American College of endocrinology Conference on the Insulin Resistance Syndrome 2002 American Association of Clinical Endocrinologists/American College of Endocrinology Washington, DC
2. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabetic Medicine 15 7 1998 539 553
3. A. Balasubramanyam New profiles of diabetic ketoacidosis: Type 1 vs type 2 diabetes and the effect of ethnicity Archives of Internal Medicine 159 19 1999 2317 2322
4. M.A. Banerji GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes Diabetes 43 6 1994 741 745
5. C. Bouchard Genetics and the metabolic syndrome International Journal of Obesity and Related Metabolic Disorders 19 Suppl. 1 1995 S52 S59
6. R.A. DeFronzo, and E. Ferrannini Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care 14 3 1991 173 194
7. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Journal of the American Medical Association 285 19 2001 2486 2497
8. E.S. Ford, W.H. Giles, and W.H. Dietz Prevalence of the metabolic syndrome among US adults: Findings from the third national health and nutrition examination survey Journal of the American Medical Association 287 3 2002 356 359
9. D.W. Foster Diabetes mellitus, in Harrison's principles of internal medicine A.S. Fauci E. Braunwald K.J. Isselbacher 1998 McGraw-Hill Book New York 2060 2080
10. S.M. Haffner Prospective analysis of the insulin-resistance syndrome (syndrome X) Diabetes 41 6 1992 715 722
11. O. Hother-Nielsen Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables Diabetes Care 11 7 1988 531 537
12. B. Isomaa Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 4 2001 683 689
13. N.M. Kaplan The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension Archives of Internal Medicine 149 7 1989 1514 1520
14. P. Koskinen C-peptide determination in the choice of treatment in diabetes mellitus Scandinavian Journal of Clinical and Laboratory Investigation 45 7 1985 589 597
15. D.E. Laaksonen Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study American Journal of Epidemiology 156 11 2002 1070 1077
16. H.M. Lakka The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men Journal of the American Medical Association 288 21 2002 2709 2716
17. A.D. Liese, E.J. Mayer-Davis, and S.M. Haffner Development of the multiple metabolic syndrome: An epidemiologic perspective Epidemiologic Reviews 20 2 1998 157 172
18. M. Maldonado Ketosis-prone diabetes: Dissection of a heterogeneous syndrome using an immunogenetic and b-cell functional classification, prospective analysis and clinical outcomes Journal of Clinical Endocrinology and Metabolism 88 2003 5090 5098
19. F. Ovalle, and D.S. Bell Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitus Diabetes Obesity & Metabolism 4 1 2002 56 59
20. G.M. Reaven Banting lecture 1988. Role of insulin resistance in human disease Diabetes 37 12 1988 1595 1607
21. E. Sobngwi, and J.F. Gautier Adult-onset idiopathic Type I or ketosis-prone Type II diabetes: Evidence to revisit diabetes classification Diabetologia 45 2 2002 283 285
22. M.P. Stern The insulin resistance syndrome K.G. Alberti P. Zimmet R. De Fronzo International textbook of diabetes mellitus 1997 Wiley Chichester 255 283
23. M. Trevisan Syndrome X and mortality: A population-based study. Risk factor and life expectancy research group American Journal of Epidemiology 148 10 1998 958 966
24. G.E. Umpierrez Diabetic ketoacidosis in obese African-Americans Diabetes 44 7 1995 790 795
25. G.E. Umpierrez Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis Diabetes Care 22 9 1999 1517 1523
26. P.Z. Zimmet Kelly west lecture 1991. Challenges in diabetes epidemiology-from West to the rest Diabetes Care 15 2 1992 232 252